Full-Time
Senior Business Analyst
Finance Operations
Curaleaf
1,001-5,000 employees
Cannabis cultivation, processing, and retailing
Compensation Overview
$110k - $123k/yr
No H1B Sponsorship
Las Vegas, NV, USA
In Person
The posting also lists Stamford, Connecticut as an available work location.
Bachelor's
 Finance & Banking (1) |
|---|
 Business & Strategy (1) |
|---|
Get referred to Curaleaf
See people who can refer or advise you
- The candidate must have 3–5 years supporting Microsoft Dynamics 365 Finance and Operations.
- The candidate must have a strong understanding of finance and accounting principles.
- The candidate must have a bachelor's degree in Information Technology, Business Administration, Finance, Accounting, or a related field.
- The candidate must have 3–5 years of experience as a Business Analyst in IT or a related field.
- The candidate must be proficient in Microsoft Office, Visio, and requirements management software; Azure DevOps is preferred.
- The candidate must have strong communication and stakeholder management abilities.
- The candidate must have strong analytical and documentation skills.
- Conduct interviews, workshops, and analysis sessions to elicit business requirements.
- Translate business needs into clear, concise functional and technical specifications.
- Develop process flows, use cases, and requirements for IT solutions.
- Support management of the demand pipeline and ensure alignment with strategic objectives.
- Work with finance and accounting teams to analyze and create requirements for finance-related systems, including enterprise resource planning, accounts payable, treasury, and financial close and consolidation systems.
- Understand key financial processes such as financial close and consolidation, cash management, general ledger, accounts payable, accounts receivable, and reporting.
- Partner with finance stakeholders to ensure compliance and accuracy in system design.
- Act as a liaison between business integrations stakeholders and information technology teams.
- Work with the information technology project management office to provide regular updates on project progress and risks.
- Facilitate workshops for requirements validation and solution design.
- Support testing activities by validating requirements and creating test plans.
- Knowledge of project management methodologies, including Agile and Waterfall.
- Advanced Excel and data analysis skills.
- Knowledge of point-of-sale systems or supply chain.
- Strong organizational skills and the ability to manage multiple priorities and deadlines.
- Strong problem-solving and critical-thinking abilities.
Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Wakefield, Massachusetts
Founded
2010
Get referred to Curaleaf
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $340.1 million, up 10%, with $12.5 million net income.
- April 2026 authorized an $83 million buyback, supporting per-share results into 2027.
- August 11, 2026 Aurora bid targets EU medical synergies and about $40 million savings.
What critics are saying
- June 30, 2026 debt was $611.5 million against $107 million cash, squeezing optionality.
- Aurora’s board can reject Curaleaf’s $4 bid, wasting management attention through late 2026.
- New Jersey appealed Curaleaf’s labor-peace win, while May 2026 health-claims class actions persist.
What makes Curaleaf unique
- July 2026 Spain registrations made Curaleaf first standardised medical cannabis supplier there.
- Four 20 Pharma gives Curaleaf EU-GMP distribution across Germany and select European markets.
- Florida scale matters: Curaleaf opened its 75th Florida dispensary on August 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Parental Leave
401(k) Retirement Plan
Life Insurance
Disability Insurance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%Curaleaf has formally launched its hostile takeover bid for Aurora Cannabis, offering $4 per share directly to shareholders. The offer represents a 45% premium on Aurora's 30-day average share price from 10 August, before Curaleaf announced its intentions. The proposed deal would create a combined company with a $3 billion market cap. Curaleaf projects approximately $40 million in annual cost synergies from the merger. The acquisition aims to give Curaleaf access to EU medical cannabis export markets, particularly Germany. Aurora possesses EU-GMP cultivation capacity that meets strict German import standards. Federal restrictions make direct cannabis exports challenging for US firms like Curaleaf. Curaleaf CEO Boris Jordan said initial friendly discussions with Aurora CEO Miguel Martin earlier this summer stalled, prompting the direct shareholder approach. Aurora's board has formed a special committee to review the offer.
Curaleaf Holdings reported second quarter 2026 revenue of $340 million, representing 10% year-over-year growth driven by domestic and international segments that grew 7% and 26%, respectively. International revenue reached $51 million. The cannabis company posted net income of $12 million and adjusted EBITDA of $70 million, reflecting a 21% margin. Gross profit margin stood at 50%. Chairman and CEO Boris Jordan said the results demonstrate the company's "Built for Growth" strategy is gaining traction. He noted this marks the second consecutive quarter of domestic year-over-year growth. Curaleaf ended the quarter with $107 million in cash and $611.5 million in outstanding debt. The company invested $32.9 million in capital expenditures during the six-month period, focused on facility upgrades and automation.
Curaleaf Holdings has opened its 75th dispensary in Florida, located in Boynton Beach. The cannabis retailer now operates 167 locations nationwide, with Florida representing nearly half of its retail footprint. The new store at 3575 W. Boynton Beach Boulevard is the company's sixth Florida opening this year. It offers medical cannabis products including Anthem pre-rolls, Dark Heart ultra-premium flower, and Select vaping products. Boris Jordan, chairman and CEO, said the opening reinforces Curaleaf's commitment to expanding access to cannabis products across Florida. A grand opening celebration is scheduled for 31 July and 1 August, featuring special promotions and giveaways. The dispensary operates 9:00 to 20:30 Monday through Saturday, and 10:00 to 18:00 on Sunday.
Curaleaf Holdings has become the first company to secure registration for standardised cannabis preparations in Spain under the country's new regulatory framework, Royal Decree 903/2025. Spain's medicines agency AEMPS approved two preparations — THC-dominant and CBD-dominant — developed by Curaleaf's Spanish manufacturing subsidiary. The registrations enable supply to hospital pharmacies, where the preparations can be used in magistral formulas under medical prescription. Royal Decree 903/2025, approved in October 2025, establishes Spain's regulatory framework for medicinal cannabis, setting production and quality standards. Curaleaf operates an EU-GMP certified manufacturing facility and R&D laboratory in Alicante. The company secured Spain's first licence to process medicinal cannabis derivatives for commercial distribution in May 2020. The preparations are expected to become available to patients through hospital pharmacies as Spain's regulated system develops.
Curaleaf Holdings has opened two new medical cannabis dispensaries in Florida, located in Jacksonville Beach and Fernandina Beach. The openings bring the company's Florida dispensary count to 73 and its nationwide total to 165 locations. The Jacksonville Beach location sits on Beach Boulevard along US Route 90, whilst the Fernandina Beach dispensary is positioned on South 8th Street along Florida State Road 200. Both stores offer Curaleaf's Florida-exclusive products, including Reef flower, Grassroots flower and Select Briq 2. Chairman and CEO Boris Jordan said the expansion reflects the company's strategy to strengthen its presence in Florida's medical cannabis market. Grand opening celebrations will take place at both locations in May, featuring live entertainment, promotions and giveaways.